(P16-03) Infuse PLF
Research payments
$999,253
Through program year 2025, $999,253 in research payments was reported against (P16-03) Infuse PLF, across 372 payments.
- Paid by (largest first)
- Medtronic, Inc.; Medtronic USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $87,217 | 51 |
| 2024 | Research | $213,451 | 71 |
| 2023 | Research | $171,161 | 76 |
| 2022 | Research | $275,813 | 48 |
| 2021 | Research | $86,150 | 51 |
| 2020 | Research | $165,461 | 75 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Joseph Smucker Carmel, IN Named on 54 payments
- Kee Kim Sacramento, CA Named on 51 payments
- Chetan Patel Altamonte Springs, FL Named on 42 payments
- Ripul Panchal Plano, TX Named on 33 payments
- John Small Temple Terrace, FL Named on 15 payments
- Gregory Wiggins Kalamazoo, MI Named on 14 payments
- Keith Michael Atlanta, GA Named on 14 payments
- Ryan Martyn Durango, CO Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.